COVID-19 boosters may be offered this fall, but first scientists need to determine what strains to target and who should receive the shots.
Advisers to the U.S. Food and Drug Administration are slated to meet Thursday to discuss plans for fall, a decision with a deadline because drugmakers will need to have the time to manufacture the shots, NBC News reported.
The process is similar to deciding on an annual flu vaccine.
